| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q1 2014 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VANGUARD INTL EQUITY INDEX F | 7 | Q2 2024 | 6.8% |
| VANGUARD INDEX FDS | 7 | Q2 2024 | 6.3% |
| DIMENSIONAL ETF TRUST | 7 | Q2 2024 | 6.0% |
| Amphastar Pharma Inc | 7 | Q2 2024 | 7.4% |
| DIMENSIONAL ETF TRUST | 7 | Q2 2024 | 4.9% |
| INVESCO QQQ TR | 7 | Q2 2024 | 4.9% |
| Vanguard US Small Cap Value | 7 | Q2 2024 | 4.4% |
| Avantis Global Real Estate/American Century | 7 | Q2 2024 | 7.3% |
| VANGUARD INTL EQUITY INDEX F | 7 | Q2 2024 | 4.4% |
| DIMENSIONAL ETF TRUST | 7 | Q2 2024 | 4.0% |
View LAM GROUP, INC.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-05 |
| 13F-HR | 2024-07-22 |
| 13F-HR | 2024-04-05 |
| 13F-HR | 2024-01-30 |
| 13F-HR | 2023-10-18 |
| 13F-HR | 2023-07-14 |
| 13F-HR | 2023-04-11 |
| 13F-HR | 2023-01-13 |
View LAM GROUP, INC.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.